Real-world treatment patterns and outcomes among metastatic cutaneous melanoma patients treated with ipilimumab, Journal of the European Academy of Dermatology and Venereology, vol.8, issue.S6, pp.962-971, 2018. ,
DOI : 10.1007/s001050050149
Baseline laboratory parameters predicting clinical outcome in melanoma patients treated with ipilimumab: a single-centre analysis, Journal of the European Academy of Dermatology and Venereology, vol.10, issue.6, pp.972-977, 2018. ,
DOI : 10.1111/j.1365-2133.2012.11212.x
, DOI: 10.1111/jdv, European Academy of Dermatology and Venereology JEADV, vol.32, p.849, 2018.